Paul Okunieff
14Patents
3h-index
10Co-inventors
53Inventor score
Filing activity: Feb 25, 2009 → Aug 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8993522B2 | Materials and methods for improving gastrointestinal function | Human Necessities | 29 | Active |
| US8404444B2 | Method for predicting the level of damage to cells by measuring free circulating Alu nucleic acid | Chemistry; Metallurgy | 14 | Active |
| US10322109B2 | Materials and methods for improving gastrointestinal function | Human Necessities | 5 | Active |
| US10940137B2 | Materials and methods for improving gastrointestinal function | Human Necessities | 3 | Active |
| US10086007B2 | Materials and methods for treatment of cystic fibrosis and for induction of ion secretion | Human Necessities | 2 | Active |
| US10350185B2 | Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications | Human Necessities | 2 | Active |
| US10758507B2 | Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications | Human Necessities | 2 | Active |
| US11576884B2 | Amino acid compositions and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11529325B2 | Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications | Human Necessities | 1 | Active |
| US9829484B2 | Use of anoctamin as a biomarker for radiation biodosimetry | Physics | 1 | Active |
| US11752132B2 | Materials and methods for improving gastrointestinal function | Human Necessities | 1 | Active |
| US8871900B2 | Fibroblast growth factor (FGF) analogs and uses thereof | Human Necessities | 0 | Active |
| US10502731B2 | Use of anoctamin as a biomarker for radiation biodosimetry | Physics | 0 | Active |
| US12239633B2 | Materials and methods for improving gastrointestinal function | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.